NCT06689085: 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
- State
- Under way
- Phase
- Phase 3
- People
- 100 planned
- Started
- 7 Mar 2025
- Primary completion
- Mar 2028
- Arms
- Participants
- Results
- None posted
- 14 Nov 2024: Trial registered
- 7 Mar 2025: Trial started